Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress

Journal of Nutritional Biochemistry

Volumn 21, Issue 9, 2010, Pages 827-833

  Aydemir Koksoy, Aslihan ^a   Bilginoglu, Ayca ^a   Sariahmetoglu, Meltem ^b   Schulz, Richard ^b   Turan, Belma ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; ALPHA ACTININ 1; ALPHA TOCOPHEROL; ANTIOXIDANT; CONTRACTILE PROTEIN; FISH OIL; GELATINASE A; NITRITE; OMEGA 3 FATTY ACID; SELENATE; THIOL DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ZYMOGRAPHY;

ACTININ; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS, OMEGA-3; HEART; MALE; MATRIX METALLOPROTEINASE 2; MYOCARDIAL CONTRACTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SELENIUM COMPOUNDS; TISSUE INHIBITOR OF METALLOPROTEINASES; TROPONIN I;

ANIMALIA; RATTUS;

EID: 77955841993     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.06.006     Document Type: Article

References (51)

1. Fein F.S., Kornstein L.B., Strobeck J.E., Capasso J.M., Sonnenblick E.H. Altered myocardial mechanics in diabetic rats. Circ Res 1980, 47:922-933.
2. Jourdon P., Feuvray D. Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol 1993, 470:411-429.
3. Xu Z., Patel K.P., Lou M.F., Rozanski G.J. Up-regulation of K+ channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovasc Res 2002, 53:80-88.
4. Ayaz M., Ozdemir S., Ugur M., Vassort G., Turan B. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys 2004, 426:83-90.
5. Ayaz M., Turan B. Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle. Am J Physiol Heart Circ Physiol 2006, 290:H1071-H1080.
6. Cheung P.Y., Sawicki G., Wozniak M., Wang W., Radomski M.W., Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 2000, 101:1833-1839.
7. Sawicki G., Leon H., Sawicka J., Sariahmetoglu M., Schulze C.J., Scott P.G., Szczesna-Cordary D., Schulz R. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 2005, 112:544-552.
8. Wang W., Sawicki G., Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res 2002, 53:165-174.
9. Viappiani S., Nicolescu A.C., Holt A., Sawicki G., Crawford B.D., Leon H., van Mulligen T., Schulz R. Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol 2009, 77(5):826-834.
10. Siwik D.A., Pagano P.J., Colucci W.S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 2001, 280:C53-C60.
11. Somerville R.P., Oblander S.A., Apte S.S. Matrix metalloproteinases: old dogs with new tricks. Genome Biol 2003, 4:216.
12. Sung M.M., Schulz C.G., Wang W., Sawicki G., Bautista-Lopez N.L., Schulz R. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol 2007, 43:429-436.
13. Ovechkin A.V., Tyagi N., Rodriguez W.E., Hayden M.R., Moshal K.S., Tyagi S.C. Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice. J Appl Physiol 2005, 99:2398-2405.
14. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 2001, 13:534-540.
15. Moshal K.S., Metreveli N., Tyagi S.C. Mitochondrial matrix metalloproteinase activation and dysfunction in hyperhomocysteinemia. Curr Vasc Pharmacol 2008, 6:84-92.
16. Nelson K.K., Melendez J.A. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 2004, 37:532-537.
17. Ryan M.E., Usman A., Ramamurthy N.S., Golub L.M., Greenwald R.A. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity. Curr Med Chem 2001, 8:305-316.
18. Wang W., Schulze C.J., Suarez-Pinzon W.L., Dyck J.R., Sawicki G., Schulz R. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 2002, 106:1543-1549.
19. Chow A.K., Cena J., Schulz R. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br J Pharmacol 2007, 152:189-205.
20. Yaras N., Sariahmetoglu M., Bilginoglu A., Aydemir-Koksoy A., Onay-Besikci A., Turan B., Schulz R. Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol 2008, 155(8):1174-1184. Epub 2008 Sep 22.
21. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008, 16(2):CD007176.
22. Morris C.D., Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003, 139:56-70.
23. Flores-Mateo G., Navas-Acien A., Pastor-Barriuso R., Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 2006, 84:762-773.
24. McNeill J.H., Delgatty H.L., Battell M.L. Insulinlike effects of sodium selenate in streptozotocin-induced diabetic rats. Diabetes 1991, 40:1675-1678.
25. Berg E.A., Wu J.Y., Campbell L., Kagey M., Stapleton S.R. Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats. Biochimie 1995, 77:919-924.
26. Tavazzi L., Tognoni G., Franzosi M.G., Latini R., Maggioni A.P., Marchioli R., Nicolosi G.L., Porcu M. GISSI-HF Investigators. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 2004, 6(5):635-641.
27. Tuncay E., Seymen A.A., Tanriverdi E., Yaras N., Tandogan B., Ulusu N.N., Turan B. Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction. Mol Cell Biochem 2007, 304:255-263.
28. Gao C.Q., Sawicki G., Suarez-Pinzon W.L., Csont T., Wozniak M., Ferdinandy P., Schulz R. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc Res 2003, 57:426-433.
29. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008, 16(2):CD007176.
30. Morris C.D., Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003, 139:56-70.
31. Flores-Mateo G., Navas-Acien A., Pastor-Barriuso R., Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 2006, 84:762-773.
32. Alkhenizan A.H., Al-Omran M.A. The role of vitamin E in the prevention of coronary events and stroke. Meta-analysis of randomized controlled trials. Saudi Med J 2004, 25:1808-1814.
33. Schulz R. Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol 2007, 47:211-242.
34. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996, 98:2572-2579.
35. Leon H., Baczko I., Sawicki G., Light P.E., Schulz R. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. Br J Pharmacol 2008, 153:676-683.
36. Yaras N., Bilginoglu A., Vassort G., Turan B. Restoration of diabetes-induced abnormal local Ca2+release in cardiomyocytes by angiotensin II receptor blockade. Am J Physiol Heart Circ Physiol 2007, 292:H912-H920.
37. Li S., Li X., Rozanski G.J. Regulation of glutathione in cardiac myocytes. J Mol Cell Cardiol 2003, 35:1145-1152.
38. Van Linthout S., Seeland U., Riad A., Eckhardt O., Hohl M., Dhayat N., Richter U., Fischer J.W., Bohm M., et al. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 2008, 103:319-327.
39. Papp L.V., Lu J., Holmgren A., Khanna K.K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007, 9:775-806.
40. McLennan P.L., Owen A.J., Slee E.L., Theiss M.L. Myocardial function, ischaemia and n-3 polyunsaturated fatty acids: a membrane basis. J Cardiovasc Med (Hagerstown) 2007, 8(Suppl 1):S15-S18.
41. Pepe S., McLennan P.L. (n-3) Long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats. J Nutr 2007, 137:2377-2383.
42. Jude S., Roger S., Martel E., Besson P., Richard S., Bougnoux P., Champeroux P., Le Guennec J.Y. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog Biophys Mol Biol 2006, 90:299-325.
43. Pierce G.N., Dhalla N.S. Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am J Physiol Endocrinol Metab 1985, 248:E170-E175.
44. Turan B., Desilets M., Acan L.N., Hotomaroglu O., Vannier C., Vassort G. Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovasc Res 1996, 32:351-361.
45. Frears E.R., Zhang Z., Blake D.R., O'Connell J.P., Winyard P.G. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett. 1996, 381:21-24.
46. Schulze C.J., Wang W., Suarez-Pinzon W.L., Sawicka J., Sawicki G., Schulz R. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myocardial] ischemia-reperfusion injury. Circulation 2003, 107:2487-2492.
47. Bloch-Damti A., Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal 2005, 7:1553-1567.
48. Ezaki O., Fukuda N., Itakura H. Role of two types of glucose transporters in enlarged adipocytes from aged obese rats. Diabetes 1990, 39:1543-1549.
49. Stapleton S.R., Garlock G.L., Foellmi-Adams L., Kletzien R.F. Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. Biochim Biophys Acta 1997, 1355:259-269.
50. Bogdanov K.Y., Spurgeon H.A., Vinogradova T.M., Lakatta E.G. Modulation of the transient outward current in adult rat ventricular myocytes by polyunsaturated fatty acids. Am J Physiol 1998, 274:H571-H579.
51. Rozanski G.J., Xu Z., Whitney R.T., Murakami H., Zucker I.H. Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing. J Mol Cell Cardiol 1997, 29:721-732.